Dietary Supplement Content Analyses On FTC Agenda For 2000
This article was originally published in The Tan Sheet
The integrity of dietary supplement nutrient content claims may come under increased scrutiny by the Federal Trade Commission in the coming months.
You may also be interested in...
FDA affirms its position that "structure/function claims should not imply disease treatment or prevention" in the agency's final rule on dietary supplement claims criteria published in the Jan. 6 Federal Register.
FDA will permit dietary supplement makers to make structure/function claims for "common, mild symptoms associated with normal life stages or processes." Examples of allowable claims include hot flashes associated with menopause and mild mood changes, cramps and edema related to the menstrual cycle.
The Federal Trade Commission either should issue advisory opinions concerning dietary supplement structure/function claim advertising or define the criteria it uses in deciding whether such ads satisfy the "competent and reliable scientific evidence" standard, four supplement marketers say in a petition for rulemaking filed with FTC Dec. 21.